The table below shows the expected mortality impact in our central scenario by market and by age
The growing interest in nutraceuticals stems from their potential to address chronic diseases, such as cardiovascular disorders, neurodegenerative conditions, and metabolic syndromes, which are often linked to oxidative stress and inflammation (5, 6)
CJC-1295, a GHRH analog, is associated with sustained increases in growth hormone and IGF-1, supporting repair and recovery
Real Stories: How GLP-1 Medications Impact Sex Lives Take a look at some personal antidotes found on social media of patients who give different viewpoints on GLP-1 usage and their sex lives
February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026
The answer comes down to study design, not magic